Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
1-15 of 253
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CEStarting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiersUncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiersRecognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiersImproving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
A Closer Look at the Biology Behind MS Progression
NeuroFrontiersA Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
- advertisement
Ethan Meltzer, MD
Exploring Genetic Links Between EBV Clearance and MS Risk
NeuroFrontiersExploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
NeuroFrontiersImplementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiersImmunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
Navigating Emerging Treatment Options in MG
NeuroFrontiersNavigating Emerging Treatment Options in MG
Qihua Fan, MD
- advertisement
New Therapies, New Strategy: Rethinking MG Inpatient Care
NeuroFrontiersNew Therapies, New Strategy: Rethinking MG Inpatient Care
Qihua Fan, MD
Shruti Raja, MD, MHS
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
